Agenus, Inc. Company Profile

14:04 EDT 24th March 2018 | BioPortfolio

Agenus is an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants. Agenus’ checkpoint modulator programs target GITR, OX40, CTLA-4, LAG-3, TIM-3 and PD-1. The company’s proprietary discovery engine Retrocyte Display® is used to generate fully human therapeutic antibody drug candidates. The Retrocyte Display platform uses a high-throughput approach incorporating IgG format human antibody libraries expressed in mammalian B-lineage cells. Agenus’ heat shock protein vaccines for cancer and infectious disease are in Phase 2 studies. The company’s QS-21 Stimulon® adjuvant platform is extensively partnered with GlaxoSmithKline and Janssen and includes several candidates in Phase 3 trials. For more information, please visit, or connect with the company on Facebook, LinkedIn, Twitter and Google+. For more information, please visit

News Articles [20 Associated News Articles listed on BioPortfolio]

Agenus To Present on Lead Antibody Programs AGEN1884 (CTLA-4) and AGEN2034 (PD-1) at SITC 2017

The Agenus strategy is built on a foundation of speed, innovation, and combinations, each critical elements for success in I-O. Agenus is delivering innovations through Read more...

Agenus to sell Stimulon adjuvant to HealthCare

HealthCare Royalty Partners will gain Agenus' royalty rights on sales of vaccines from GlaxoSmithKline containing Agenus' QS- -More- 

Agenus enters $230mm royalty sale agreement with Healthcare Royalty

Immuno-oncology firm Agenus Inc. entered a $230mm royalty sale agreement with Healthcare Royalty Partners, which will pay $190mm in cash up front in exchange for royalties Agenus is eligible to receiv...

Agenus (AGEN) Upgraded at BidaskClub

A number of other analysts have also weighed in on AGEN. Zacks Investment Research raised shares of Agenus from a "hold" rating to a "buy" rating and set a $4.50 target price on the stock in a report ...

Immuno-oncology company Agenus to cut 50 jobs in reorganization

Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and vaccine program.

Investor Network: Agenus Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 15, 2018 / Agenus Inc. (NASDAQ: AGEN) will be discussing their earnings results in their Q4 Earnings Call to be held on March 15, 2018 at 11:00 AM Eastern Time. To...

Agenus Inc (AGEN) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Agenus Inc have been assigned an average recommendation of "Hold" from the six ratings firms that are presently covering the company, reports. Two research analysts have rated...

Agenus: Mystery Therapy Indicates Possible Upside

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Agenus, Inc.

Agenus is an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants. Agenus’ checkpoint modulator programs ...

Agenus Inc.

Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong plat...

Incyte and Agenus

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs, prima...

More Information about "Agenus, Inc." on BioPortfolio

We have published hundreds of Agenus, Inc. news stories on BioPortfolio along with dozens of Agenus, Inc. Clinical Trials and PubMed Articles about Agenus, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agenus, Inc. Companies in our database. You can also find out about relevant Agenus, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record